Forecasting Future Advances Across Oncology

Season 4, Episode 24,   Jan 21, 2021, 09:39 PM

Headliner
Share
Subscribe

In our exclusive interviews, each expert discussed their expectations for research and drug development in oncology in the new year.

Share
Subscribe
Next
FDA Approval Insights: Nivolumab/Cabozantinib in Advanced RCC
Top episodes
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air
Wise Summarizes Survival Data From ARASENS and PEACE-1 in Prostate Cancer
by OncLive® On Air